The total issue size of Aptus Pharma IPO is up to ₹12.36 Cr whereas the issue size of the Earkart IPO is up to ₹46.76 Cr. The final issue price of Aptus Pharma IPO is ₹70.00 per share and of Earkart IPO is ₹135.00 per share.
Aptus Pharma IPO opens on Sep 23, 2025, while Earkart IPO opens on Sep 25, 2025. The closing date of Aptus Pharma IPO and Earkart IPO is Sep 25, 2025, and Sep 29, 2025, respectively.
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered 6,20,000 shares while in Earkart IPO retail investors are offered 6,20,000 shares. Qualified Institutional Buyers (QIB) are offered 3,52,000 shares in Aptus Pharma IPO and 0 shares in Earkart IPO.